Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Tag: immunotherapy
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
Elizabeth M. Jaffee and Antoni Ribas will look to feature the next wave of immuno-oncology advances as Cancer Immunology Research's...
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
Cancer Today's 2025 summer issue covers the expanded use of neoadjuvant immunotherapy, PSMA-targeted therapy for prostate cancer, and more.
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR...
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...